Fig. 6: Cell cytotoxicity of SCC EPHA2 isogenic cells with chemo drugs and small molecular inhibition.

BEAS2B EPHA2 isogenic cells were used to treat a Taxol, b cisplatin, c SU11274, and d rapamycin. Mutation G391R cells showed resistant to cisplatin inhibition but sensitive to MET inhibitor SU11274 and mTOR inhibitor Rapamycin. EV: empty vector